rhenium has been researched along with Disease Models, Animal in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.44) | 18.2507 |
| 2000's | 20 (48.78) | 29.6817 |
| 2010's | 20 (48.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
| Avril, S; Chourpa, I; Davodeau, F; Garcion, E; Griveau, A; Hindré, F; Legendre, C; Lepareur, N; Loussouarn, C; Séhédic, D; Tétaud, C; Wion, D | 1 |
| Ananthakrishnan, L; Lenkinski, RE; Lewis, MA; Nasr, K; Soesbe, TC | 1 |
| Bokharaei, M; De La Vega, JC; Esquinas, PL; Häfeli, UO; Liu, D; Moskalev, I; Rodríguez-Rodríguez, C; Saatchi, K | 1 |
| Huang, PW; Kao, CH; Lin, WY; Luo, TY; Tsai, SC | 1 |
| Bryan, RA; Casadevall, A; Dadachova, E; Jandl, T; Jiang, Z; Revskaya, E | 1 |
| Cui, M; Fu, H; Jia, H; Jia, J; Jin, B; Li, Z; Liu, B; Wang, X; Yang, Y; Yu, P | 1 |
| Dadachova, E; Fisher, DR; Goldberg, GL; Jiang, Z; Phaeton, R; Revskaya, E | 1 |
| Fichna, J; Pawlak, W; Siczek, K; Zatorski, H | 1 |
| Bao, A; Goins, BA; Perez, R; Phillips, WT; Soundararajan, A | 1 |
| Bergmann, R; Geidel, HH; Haase, M; Kotzerke, J; Liepe, K; Runge, R | 1 |
| Chang, CH; Chang, TJ; Chang, YJ; Chen, LC; Chen, MH; Lee, TW; Ting, G; Yu, CY | 1 |
| Dong, KR; Han, KH; Kim, TH; Oh, SJ; Park, IK; Shin, JH; Woo, CW | 1 |
| Fuchigami, T; Haratake, M; Ikeoka, R; Kimura, H; Nakayama, M; Ono, M; Saji, H; Watanabe, H | 1 |
| Aubé, C; Benoît, JP; Bouchet, F; Couturier, O; Garcion, E; Garin, E; Hindré, F; Lacoeuille, F; Lepareur, N; Noiret, N; Oberti, F; Roux, J; Vanpouille-Box, C | 1 |
| Chan, SH; Chang, Y; Kung, HC; Lin, WJ; Lin, WY; Liu, SW; Luo, TY; Peng, CL; Tang, IC | 1 |
| Bao, A; Goins, BA; McManus, LM; Phillips, WT; Soundararajan, A | 1 |
| Bao, A; Hrycushko, BA; Li, S; Ware, S | 1 |
| Bao, A; Dodd, GD; Goins, BA; McManus, LM; Phillips, WT; Prihoda, TJ; Soundararajan, A | 1 |
| Chang, CH; Lan, KL; Lee, TW; Lee, WC; Liu, CM; Ting, G; Yu, CY | 1 |
| Chang, CH; Chen, WJ; Huang, FY; Kao, CH; Lee, TW; Lee, WY; Lo, JM; Wang, SC; Zhang, X | 1 |
| Chang, CH; Chang, YJ; Chen, LC; Hsu, CW; Lan, KL; Lee, TW; Ting, G | 1 |
| Izumo, M; Kinuya, S; Michigishi, T; Mori, H; Obata, T; Shiba, K; Shuke, N; Sorita, T; Tonami, N; Watanabe, N; Yokoyama, K | 2 |
| Gupta, SK; Ingle, AD; Mukherjee, A; Pandey, U; Pillai, MR; Sarma, HD; Venkatesh, M | 1 |
| Buecker, A; Büll, U; Görgen, T; Günther, RW; Heussen, N; Kulisch, A; Meyer, JM; Moltzahn, F; Nowak, B; Schuermann, K | 1 |
| Fisher, DR; Hoffman, TJ; Miao, Y; Owen, NK; Quinn, TP | 1 |
| Huang, K; Li, G; Peng, W; Wang, Y; Zhang, C; Zhang, H | 1 |
| Azhdarinia, A; Bryant, J; Kim, EE; Kohanim, S; Mendez, R; Oh, C; Yang, DJ; Yu, DF | 1 |
| Huang, YS; Hung, GU; Lee, JC; Lin, WY; Lin, YC; Tsai, SC | 1 |
| Benoit, JP; Bourguet, P; Denizot, B; Garin, E; Herry, JY; Laurent, JF; Lejeune, JJ; Lepareur, N; Mesba, H; Moreau, M; Noiret, N; Roux, J | 1 |
| Daly, T; Descalle, MA; Fisher, D; Hartmann-Siantar, C; Hoffman, T; Lehmann, J; Lewis, MR; Miller, WH; Situ, PD; Smith, J; Volkert, WA | 1 |
| Dadachova, E; Gnatovskiy, L; Lin, EY; Lu, P; Nguyen, A; Pollard, JW | 1 |
| Azqueta, A; Cerecetto, H; Fernández, M; Giglio, J; González, M; León, A; León, E; López de Ceráin, A; Monge, A; Paolino, A; Papadopoulos, M; Pirmettis, I; Rey, A | 1 |
| Häfeli, UO; Pauer, GJ; Prayson, RA; Unnithan, J | 1 |
| Asano, D; Hashimoto, K; Kawashima, H; Kinuya, S; Mori, H; Mukai, T; Ogawa, K; Saji, H; Shiba, K | 1 |
| Hobbelink, MG; Nijsen, JF; van Het Schip, AD; Vente, MA; Zonnenberg, BA | 1 |
| Deng, HF; Jia, ZY; Luo, SZ; Pu, MF | 1 |
| Aguiar, J; Bernardo, J; Botelho, MF; de Lima, JJ; Ferreira, N; Gonçalves, L; Pacheco, MF; Pauwels, EK; Providência, LA; Santos, AC; Sousa, P | 1 |
| Baumbach, A; Brehme, U; Claussen, CD; Dietrich, T; Dinkelborg, LM; Duda, SH; Greschniok, A; Muschick, P; Noll, B; Tepe, G | 1 |
| Chen, G; Jiang, X; Li, P; Sun, Z; Wang, X; Zhang, H; Zhang, L | 1 |
2 review(s) available for rhenium and Disease Models, Animal
| Article | Year |
|---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Radionuclide liver cancer therapies: from concept to current clinical status.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Delivery Systems; Holmium; Humans; Iodine Radioisotopes; Liver; Liver Neoplasms; Microspheres; Prognosis; Radiopharmaceuticals; Rhenium; Yttrium Radioisotopes | 2007 |
39 other study(ies) available for rhenium and Disease Models, Animal
| Article | Year |
|---|---|
Locoregional Confinement and Major Clinical Benefit of
Topics: Animals; Blood-Brain Barrier; Brain; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Female; Glioblastoma; Humans; Lipids; Mice; Nanocapsules; Nanoparticles; Neoplastic Stem Cells; Radioisotopes; Radiopharmaceuticals; Receptors, CXCR4; Rhenium; Xenograft Model Antitumor Assays | 2017 |
Separating High-Z Oral Contrast From Intravascular Iodine Contrast in an Animal Model Using Dual-Layer Spectral CT.
Topics: Administration, Oral; Animals; Computer Simulation; Contrast Media; Disease Models, Animal; Female; Humans; Injections, Intravenous; Intestines; Iodine; Rats, Inbred F344; Rhenium; Tantalum; Tomography, X-Ray Computed; Tungsten | 2019 |
Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Carriers; Embolization, Therapeutic; Humans; In Vivo Dosimetry; Liver Neoplasms; Microspheres; Polyesters; Radioisotopes; Radiotherapy; Rats, Sprague-Dawley; Rhenium; Treatment Outcome | 2019 |
Therapeutic efficacy of 188Re-MN-16ET lipiodol in an animal model of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Disease Models, Animal; Ethiodized Oil; Glycine; Liver Neoplasms; Male; Palmitic Acids; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rhenium; Survival Rate; Treatment Outcome; Tumor Burden | 2013 |
Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma.
Topics: Animals; Antibodies, Monoclonal; Antibody-Dependent Cell Cytotoxicity; Blotting, Western; Complement C3; Disease Models, Animal; Flow Cytometry; Humans; Melanins; Melanoma; Mice; Radioimmunotherapy; Rhenium | 2013 |
(99m)Tc-labeled dibenzylideneacetone derivatives as potential SPECT probes for in vivo imaging of β-amyloid plaque.
Topics: Amyloid beta-Peptides; Animals; Butanones; Disease Models, Animal; Fluorescent Dyes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Molecular Imaging; Molecular Structure; Organometallic Compounds; Peptide Fragments; Plaque, Amyloid; Rhenium; Staining and Labeling; Technetium; Tomography, Emission-Computed, Single-Photon | 2013 |
Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.
Topics: Animals; Beta Particles; Cell Line, Tumor; Disease Models, Animal; DNA Damage; Female; Humans; Immunoconjugates; Lutetium; Mice; Papillomavirus Infections; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Rhenium-coated glass beads for intracolonic administration attenuate TNBS-induced colitis in mice: Proof-of-Concept Study.
Topics: Animals; Anti-Inflammatory Agents; Biocompatible Materials; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Glass; Mice; Mice, Inbred BALB C; Rhenium; Trinitrobenzenesulfonic Acid | 2015 |
[(186)Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Disease Models, Animal; Doxorubicin; Drug Stability; Feasibility Studies; Head and Neck Neoplasms; Humans; Male; Radioisotopes; Rats; Rhenium; Staining and Labeling; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Transplantation, Heterologous | 2009 |
Autoradiographic studies of rhenium-188-hydroxyethylidine diphosphonate in normal skeleton and osteoblastic bone metastases in a rat model of metastatic prostate cancer.
Topics: Animals; Autoradiography; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Etidronic Acid; Lumbar Vertebrae; Male; Osteoblasts; Prostatic Neoplasms; Radioisotopes; Rats; Rhenium; Tissue Distribution | 2009 |
Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.
Topics: Animals; Autoradiography; Cell Line, Tumor; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Drug Stability; Drug Therapy; Injections, Intravenous; Male; Maximum Tolerated Dose; Mice; Radioisotopes; Radiotherapy; Rhenium; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tumor Burden; X-Ray Microtomography | 2010 |
Inhibition of neointimal hyperplasia after stent placement with rhenium 188-filled balloon dilation in a canine iliac artery model.
Topics: Animals; Blood Vessel Prosthesis; Catheterization; Disease Models, Animal; Dogs; Graft Occlusion, Vascular; Humans; Iliac Artery; Isotopes; Radiopharmaceuticals; Rhenium; Stents; Treatment Outcome | 2010 |
99mTc/Re complexes based on flavone and aurone as SPECT probes for imaging cerebral β-amyloid plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzofurans; Brain; Coordination Complexes; Disease Models, Animal; Flavones; Mice; Molecular Probes; Organotechnetium Compounds; Peptide Fragments; Plaque, Amyloid; Radiopharmaceuticals; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2010 |
Lipid nanocapsules loaded with rhenium-188 reduce tumor progression in a rat hepatocellular carcinoma model.
Topics: Animals; Carcinoma, Hepatocellular; Catheterization; Disease Models, Animal; Disease Progression; Kinetics; Lipids; Liver Neoplasms; Magnetic Resonance Imaging; Male; Nanocapsules; Radioisotopes; Rats; Rats, Wistar; Rhenium; Survival Analysis; Tissue Distribution; Transaminases; Tumor Burden; Vascular Endothelial Growth Factor A | 2011 |
Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Coordination Complexes; Disease Models, Animal; Ethiodized Oil; Glycine; Liver Neoplasms; Male; Palmitic Acids; Radiochemistry; Radioisotopes; Rats; Rhenium; Stearates; Tomography, Emission-Computed, Single-Photon | 2011 |
Chemoradionuclide therapy with 186re-labeled liposomal doxorubicin: toxicity, dosimetry, and therapeutic response.
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Head and Neck Neoplasms; Humans; Male; Radioisotopes; Radiometry; Radiopharmaceuticals; Rats; Rats, Nude; Rhenium; Xenograft Model Antitumor Assays | 2011 |
Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.
Topics: Algorithms; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Radiation; Head and Neck Neoplasms; Humans; Infusions, Intralesional; Liposomes; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rats; Rats, Nude; Rhenium; Transplantation, Heterologous; Treatment Outcome | 2011 |
Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.
Topics: Analysis of Variance; Animals; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Catheter Ablation; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Drug Synergism; Head and Neck Neoplasms; Isotope Labeling; Liposomes; Nuclear Medicine; Radionuclide Imaging; Radiopharmaceuticals; Random Allocation; Rats; Rats, Nude; Rhenium; Transplantation, Heterologous | 2011 |
Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Female; Injections, Intravenous; Liposomes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radioisotopes; Rhenium; Survival Rate; Tissue Distribution | 2012 |
Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.
Topics: Animals; Autoradiography; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Glioma; Isotope Labeling; Liposomes; Male; Nanoparticles; Radioisotopes; Radiopharmaceuticals; Rats; Rhenium; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2011 |
Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Fluorouracil; Humans; Liposomes; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Radionuclide Imaging; Radiopharmaceuticals; Random Allocation; Rhenium; Xenograft Model Antitumor Assays | 2012 |
Feasibility of 186Re-radioimmunotherapy for treatment in an adjuvant setting of colon cancer.
Topics: Animals; Colonic Neoplasms; Disease Models, Animal; Female; Humans; Immunoconjugates; Iodine Radioisotopes; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Rhenium | 2003 |
Bioevaluation of radioactive bandages in a murine model of melanoma.
Topics: Animals; Bandages; Brachytherapy; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Male; Melanoma; Mice; Mice, Inbred C57BL; Radioisotopes; Radiotherapy Dosage; Rhenium; Skin Neoplasms; Treatment Outcome | 2003 |
Inhibition of neointimal proliferation with 188Re-labeled self-expanding nitinol stent in a sheep model.
Topics: Alloys; Animals; Coronary Restenosis; Disease Models, Animal; Follow-Up Studies; Prosthesis Implantation; Radioisotopes; Rhenium; Sheep; Stents; Tunica Intima | 2003 |
Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Disease Models, Animal; Drug Delivery Systems; Humans; Melanoma; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Organ Specificity; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Survival Analysis; Tissue Distribution; Treatment Outcome | 2005 |
The experimental study on the radioimmunotherapy of the nasopharyngeal carcinoma overexpressing HER2/neu in nude mice model with intratumoral injection of 188Re-herceptin.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Body Burden; Cell Line, Tumor; Disease Models, Animal; Injections, Intralesional; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Organ Specificity; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Relative Biological Effectiveness; Rhenium; Tissue Distribution; Trastuzumab; Treatment Outcome | 2005 |
Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart.
Topics: Animals; Antibodies, Monoclonal; Colonic Neoplasms; Disease Models, Animal; Injections, Intraperitoneal; Iodine Radioisotopes; Maximum Tolerated Dose; Mice; Peritoneal Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution | 2005 |
Regional radiochemotherapy using in situ hydrogel.
Topics: Animals; Brachytherapy; Cisplatin; Disease Models, Animal; Drug Carriers; Drug Screening Assays, Antitumor; Hydrogels; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Radionuclide Imaging; Radiotherapy Dosage; Rats; Rhenium; Technology, Pharmaceutical | 2005 |
Direct injection of (188)Re-microspheres in the treatment of hepatocellular carcinoma: compared with traditional percutaneous ethanol injection: an animal study.
Topics: Animals; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Disease Models, Animal; Liver Neoplasms; Microspheres; Rabbits; Radionuclide Imaging; Rhenium; Treatment Outcome | 2005 |
Description and technical pitfalls of a hepatoma model and of intra-arterial injection of radiolabelled lipiodol in the rat.
Topics: Anesthetics; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Models, Animal; Female; Injections, Intra-Arterial; Iodine Radioisotopes; Iodized Oil; Isoflurane; Ketamine; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Time Factors | 2005 |
Evaluation of beta-absorbed fractions in a mouse model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu radionuclides.
Topics: Animals; Copper Radioisotopes; Disease Models, Animal; Holmium; Lutetium; Mice; Mice, Nude; Models, Statistical; Models, Theoretical; Promethium; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Rhenium; Tissue Distribution; Yttrium Radioisotopes | 2005 |
Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Drug Delivery Systems; Female; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Symporters; Treatment Outcome | 2005 |
Design and evaluation of "3 + 1" mixed ligand oxorhenium and oxotechnetium complexes bearing a nitroaromatic group with potential application in nuclear medicine oncology.
Topics: Animals; Cell Line; Cell Proliferation; China; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Gamma Cameras; Hypoxia; Ligands; Mice; Molecular Structure; Neoplasms, Experimental; Nitrobenzenes; Organometallic Compounds; Organotechnetium Compounds; Rhenium; Sensitivity and Specificity; Structure-Activity Relationship; Tissue Distribution; Xenograft Model Antitumor Assays | 2006 |
Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres.
Topics: Adhesiveness; Animals; Brachytherapy; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Fibrin Tissue Adhesive; Gels; Glioblastoma; Isotopes; Microspheres; Neoplasm Transplantation; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Radiotherapy, Adjuvant; Rats; Rats, Sprague-Dawley; Rhenium; Time Factors | 2007 |
Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.
Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Female; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Organometallic Compounds; Pain; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Time Factors | 2007 |
Rhenium-188 labelled meso-tetrakis[3,4-bis(carboxymethyleneoxy)phenyl] porphyrin for targeted radiotherapy: preliminary biological evaluation in mice.
Topics: Animals; Disease Models, Animal; Drug Stability; Hydrogen-Ion Concentration; Kinetics; Liver Neoplasms; Liver Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Organometallic Compounds; Porphyrins; Radiopharmaceuticals; Rhenium; Tissue Distribution | 2008 |
Cardiac lymphatic dynamics after ischemia and reperfusion--experimental model.
Topics: Animals; Colloids; Disease Models, Animal; Dogs; Female; Heart; Lymphatic System; Male; Myocardial Ischemia; Myocardial Reperfusion; Radioactive Tracers; Radionuclide Imaging; Reperfusion Injury; Rhenium; Technetium Tc 99m Sulfur Colloid; Time Factors | 1998 |
Prophylaxis of restenosis with (186)re-labeled stents in a rabbit model.
Topics: Animals; Aorta, Abdominal; Arterial Occlusive Diseases; Brachytherapy; Disease Models, Animal; Dose-Response Relationship, Radiation; Endothelium, Vascular; Fibrin; Half-Life; Male; Rabbits; Radioisotopes; Rhenium; Stents; Time Factors; Tunica Intima; Tunica Media | 2001 |
[Study of radiation synovectomy using (188)Re-Sulfide in hemophilic arthritis].
Topics: Animals; Chlorides; Disease Models, Animal; Follow-Up Studies; Hemophilia A; Humans; Injections, Intra-Articular; Rabbits; Rhenium; Ruthenium Radioisotopes; Sulfides; Synovial Membrane; Synovitis | 2002 |